[Federal Register Volume 66, Number 59 (Tuesday, March 27, 2001)]
[Notices]
[Page 16678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-7447]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Epidemiology Research Needs Related to the Radiofrequency Energy 
From Wireless Phones

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
meeting to discuss the health effects of radio frequency (RF) emissions 
from wireless phones. Currently, the scientific literature relating to 
the health effects of low level exposure to RF does not demonstrate the 
existence of any health risk from wireless phones. National and 
international scientific experts will discuss the need for research 
into the incidence, distribution, and control of any adverse effects 
related to RF energy from wireless phones. This meeting is being 
convened as part of the Cooperative Research and Development Agreement 
(CRADA) between FDA's Center for Devices and Radiological Health and 
the Cellular Telecommunications Industry Association (CTIA).
    Date and Time: The meeting will be held on April 18, 2001, 8:30 
a.m. to 5 p.m. and on April 19, 2001, 8:30 a.m. to 5 p.m.
    Location: The meeting will be held at The Regal Cincinnati Hotel, 
Colonnada B, second floor, 150 West Fifth St., Cincinnati, OH.
    Contact: Russell D. Owen, Center for Devices and Radiological 
Health, Food and Drug Administration (HFZ-114), 12709 Twinbrook Pkwy., 
Rockville, MD 20857, 301-443-7118, FAX 301-594-6775. Further 
information about the CRADA is available on the Internet at: http://www.fda.gov/cdrh/ocd/wlessphonecrada.html.
    Agenda: On April 18, 2001, completed and ongoing epidemiology 
studies will be reviewed and scientific questions that have been raised 
by this research will be discussed. On April 19, 2001, specific studies 
that could address these scientific questions will be discussed.
    Procedure: Interested persons may present scientific information 
relevant to items on the agenda. Written submissions may be made to the 
contact person by April 6, 2001. Oral presentations from the public 
will be scheduled on April 18, 2001, between 3 p.m. and 5 p.m. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before April 
1, 2001, and submit a brief statement of the general nature of the 
information they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.
    If you need special accommodations due to a disability, please 
contact Abiy B. Desta, 301-443-7192 at least 7 days in advance.

    Dated: March 20, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-7447 Filed 3-26-01; 8:45 am]
BILLING CODE 4160-01-S